• Citer

Prospective validation obtained in a similar group of patients and with similar high throughput biological tests failed to confirm signatures for prediction of response to chemotherapy and survival in advanced NSCLC: a prospective study from the European Lung Cancer Working Party

par Berghmans, Thierry ;Ameye, Lieveke;Lafitte, Jean-Jacques;Colinet, Benoît;Cortot, A.;Cs Toth, Ingrid ;Holbrechts, Stéphane;Lecomte, Jacques;Mascaux, Céline ;Meert, Anne-Pascale ;Paesmans, Marianne ;Richez, Michel;Scherpereel, Arnaud;Tulippe, Christian;Willems, Lucas ;Dernies, Tiffany ;Leclercq, Nathalie ;Sculier, Jean-Paul
Référence Frontiers in oncology, 4, page (1-16), 386
Publication Publié, 2015-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Prospective validation obtained in a similar group of patients and with similar high throughput biological tests failed to confirm signatures for prediction of response to chemotherapy and survival in advanced NSCLC: a prospective study from the European Lung Cancer Working Party
Auteur:	Berghmans, Thierry; Ameye, Lieveke; Lafitte, Jean-Jacques; Colinet, Benoît; Cortot, A.; Cs Toth, Ingrid; Holbrechts, Stéphane; Lecomte, Jacques; Mascaux, Céline; Meert, Anne-Pascale; Paesmans, Marianne; Richez, Michel; Scherpereel, Arnaud; Tulippe, Christian; Willems, Lucas; Dernies, Tiffany; Leclercq, Nathalie; Sculier, Jean-Paul
Informations sur la publication:	Frontiers in oncology, 4, page (1-16), 386
Statut de publication:	Publié, 2015-01
Sujet CREF:	Médecine pathologie humaine
	Cancérologie
Mots-clés:	non small cell lung cancer, mRNA, miRNA, chemotherapy, survival
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:2234-943X
	info:doi/10.3389/fonc.2014.00386
	info:scp/85006198659
	info:pmid/25674536
	PMC4309174